Hana Biosciences, Inc.;The Board of Regents,The University of Texas System
发明人:
申请号：
EP10011105.3
公开号：
EP2266537A3
申请日:
2000.03.31
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
Liposome-encapsulated vincristine is provided for treating a cancer such as a lymphoma, leukaemia or myeloma and especially non-Hodgkin's Lymphoma or Acute Lymphocytic Leukaemia. The liposomes comprise sphingomyelin and cholesterol in a ratio between 75/25 (mol % sphingomyelin/mol % cholesterol) and 50/50 (mol % sphingomyelin/mol % cholesterol) and vincristine at a concentration of 0.1 to 0.5 mg/ml.
